Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGAR

K-Number: K933122 · 1994-02-09

ApplicantBioclinical Systems, Inc.
Decision Date1994-02-09
Product CodeJTY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGAR is the device name listed in this FDA 510(k) record. The listed applicant is Bioclinical Systems, Inc.. It received FDA 510(k) clearance on 1994-02-09 under 510(k) number K933122. The device is classified under product code JTY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGAR?

MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGAR is a medical device that received FDA 510(k) clearance on 1994-02-09. The listed applicant is Bioclinical Systems, Inc.. The 510(k) number is K933122.

When did MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGAR receive FDA 510(k) clearance?

MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGAR received FDA 510(k) clearance on 1994-02-09, under 510(k) number K933122.

Who is the listed applicant for MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGAR?

The FDA 510(k) record lists Bioclinical Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGAR?

The FDA product code for MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGAR is JTY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Bioclinical Systems, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K950196CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIAK945911CULTURE MEDIA, ANTIMICROBIAL SUSCEPTIBILITY TEST, MUELLER HINTON AGARSK933121MICROBIOLOGICAL CULTURE MEDIA,CHOCOLATE AGARK873086ROUND 1K860334VISI-CHECK HLH TEST MONOCLONALK860333MICRO-ELISA HLH TEST KIT MONOCLONAL

View all 13 devices →

Related Devices (Code: JTY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K210511InTray GCBiomed Diagnostics IncorporatedK993033INTRAY GCBiomed Diagnostics, Inc.K954986GC BASE W/ 1% GCHIRemel, L.P.K950196CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIABioclinical Systems, Inc.K933121MICROBIOLOGICAL CULTURE MEDIA,CHOCOLATE AGARBioclinical Systems, Inc.K934331THAYER MARTIN, MODIFIED PILL POCKETHardy Diagnostics

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑